Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 04 Jan 2024

A pan-cancer analysis of the prognostic implication and oncogenic role of tubulin epsilon and delta complex 2 (TEDC2) in human tumors

in Cancer Immunity and Immunotherapy

Yang Liu
Jie Zhu
Jing Shen
Yuting Lu
Ke Pan
Chuan Tong
Yao Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1272108

3,914 views
1 citation

Original Research

Published on 04 Jan 2024

MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection

in Cancer Immunity and Immunotherapy

Marten Meyer
Christina Parpoulas
Titouan Barthélémy
Jonas P. Becker
Pornpimol Charoentong
Yanhong Lyu
Selina Börsig
Nadja Bulbuc
Claudia Tessmer
Lisa Weinacht

Frontiers in Immunology

doi 10.3389/fimmu.2023.1294565

7,726 views
3 citations

Original Research

Published on 04 Jan 2024

Metabolomics-transcriptomics joint analysis: unveiling the dysregulated cell death network and developing a diagnostic model for high-grade neuroblastoma

in Cancer Immunity and Immunotherapy

Wancun Zhang
Mengxin Zhang
Meng Sun
Minghui Hu
Muchun Yu
Jushan Sun
Xianwei Zhang
Bang Du

Frontiers in Immunology

doi 10.3389/fimmu.2023.1345734

2,572 views
3 citations

Review

Published on 04 Jan 2024

Nanomedicine for cancer targeted therapy with autophagy regulation

in Cancer Immunity and Immunotherapy

Ketai He
Mingkun Chen
Jiao Liu
Shufang Du
Changyu Ren
Jifa Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1238827

3,400 views
4 citations

Review

Published on 04 Jan 2024

Targeting HER3 to overcome EGFR TKI resistance in NSCLC

in Cancer Immunity and Immunotherapy

Qiuqiang Chen
Gang Jia
Xilin Zhang
Wenxue Ma

Frontiers in Immunology

doi 10.3389/fimmu.2023.1332057

10,661 views
12 citations

Original Research

Published on 03 Jan 2024

Chemical immune conization of precancerous cervical lesions awakens immune cells and restores normal HPV negative and abnormal proliferation

in Cancer Immunity and Immunotherapy

Xueping Liu
Baofa Yu
Feng Gao
Peng Jing
Peicheng Zhang
Guoqin Zheng
Xiaomin Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1259723

2,786 views
2 citations

Original Research

Published on 03 Jan 2024

Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer

in Cancer Immunity and Immunotherapy

Chunzhen Li
Lanjie Yang
Yunyan Zhang
Qianshan Hou
Siyi Wang
Shaoteng Lu
Yijie Tao
Wei Hu
Liyuan Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2023.1307588

6,080 views
11 citations

Original Research

Published on 03 Jan 2024

Circulating immunophenotypes are potentially prognostic in follicular cell-derived thyroid cancer

in Cancer Immunity and Immunotherapy

Anupam Kotwal
Michael P. Gustafson
Svetlana Bornschlegl
Allan B. Dietz
Danae Delivanis
Mabel Ryder

Frontiers in Immunology

doi 10.3389/fimmu.2023.1325343

2,899 views
7 citations

Case Report

Published on 03 Jan 2024

Neoadjuvant chemoimmunotherapy achieved a pathologic complete response in stage IIIA lung adenocarcinoma harboring RET fusion: a case report

in Cancer Immunity and Immunotherapy

Minqian Dai
Na Wang
Qin Xia
Yongde Liao
Wei Cao
Jun Fan
Diwei Zhou
Sihua Wang
Xiu Nie

Frontiers in Immunology

doi 10.3389/fimmu.2023.1258762

1,864 views
1 citation

Original Research

Published on 03 Jan 2024

Impaired activation of plasmacytoid dendritic cells via toll-like receptor 7/9 and STING is mediated by melanoma-derived immunosuppressive cytokines and metabolic drift

in Cancer Immunity and Immunotherapy

Matilde Monti
Giorgia Ferrari
Valentina Grosso
Francesco Missale
Mattia Bugatti
Valeria Cancila
Stefania Zini
Agnese Segala
Luca La Via
Francesca Consoli

Frontiers in Immunology

doi 10.3389/fimmu.2023.1227648

5,176 views
4 citations

Case Report

Published on 03 Jan 2024

Case report: Interstitial implantation radiotherapy combined with immunotherapy and GM-CSF in oligometastatic platinum-resistant ovarian cancer

in Cancer Immunity and Immunotherapy

Yi Qin
Shangke Huang
Junli Tang
Yu Fan
Xiangyu Deng
Ping Guan
Zhenhua Zhang
Qinglian Wen
Dan Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1329951

1,913 views
2 citations

Original Research

Published on 03 Jan 2024

TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion

in Cancer Immunity and Immunotherapy

Huadong Wu
Zhenzhen Fu
Hong Li
Feifei Fang
Bin He
Yujie Ye
Heyong Wu
Dong Xu
Haoran Zheng
Qiang Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1290839

3,375 views
2 citations

Original Research

Published on 03 Jan 2024

Integrative analysis of disulfidptosis and immune microenvironment in hepatocellular carcinoma: a putative model and immunotherapeutic strategies

in Cancer Immunity and Immunotherapy

Ti Yang
Junhao Liu
Fang Liu
Jiashun Lei
Siliang Chen
Zengxin Ma
Peifeng Ke
Qiaolan Yang
Jianfan Wen
Yifeng He

Frontiers in Immunology

doi 10.3389/fimmu.2023.1294677

4,628 views
4 citations

Original Research

Published on 03 Jan 2024

Apatinib combined with camrelizumab in the treatment of recurrent/metastatic nasopharyngeal carcinoma: a prospective multicenter phase II study

in Cancer Immunity and Immunotherapy

Yunyan Mo
Yufei Pan
Bin Zhang
Jian Zhang
Yixin Su
Zhengchun Liu
Meiqing Luo
Guanjie Qin
Xiangyun Kong
Rongjun Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1298418

2,925 views
5 citations

Original Research

Published on 03 Jan 2024

NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens

in Cancer Immunity and Immunotherapy

Galaxia M. Rodriguez
Edward Yakubovich
Humaira Murshed
Vincent Maranda
Kristianne J.C. Galpin
Alison Cudmore
Andrew M. R. Hanna
Elizabeth Macdonald
Shashankan Ramesh
Kenneth Garson

Frontiers in Immunology

doi 10.3389/fimmu.2023.1295208

3,388 views
5 citations

Original Research

Published on 28 Dec 2023

Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model

in Cancer Immunity and Immunotherapy

J. Bryan Iorgulescu
Neil Ruthen
Ryuhjin Ahn
Eleni Panagioti
Prafulla C. Gokhale
Martha Neagu
Maria C. Speranza
Benjamin K. Eschle
Kara M. Soroko
Raziye Piranlioglu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1297932

7,930 views
3 citations